Genes & Diseases
Издатель: Elsevier · ISSN 2352-3042 · 59 статей
- ASCL2-driven SMOC2 expression enables colorectal cancer malignant self-sufficiency via boosting TGF-β1/SMAD3-mediated EMT program
- Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator
- A candidate PTPN5 frameshift variant in a family with a neurodevelopmental disorder supported by a zebrafish loss-of-function model
- Patient-specific iPSCs-derived neuronal models of spinocerebellar ataxia type 1 as a platform for studying calcium mishandling
- Phase separation of Snail1 modulates transcription and cancer progression
- Single-cell transcriptome analysis highlights conserved transcriptional responses across multiple models of Retinitis Pigmentosa
- Expanding the phenotypic spectrum of familial digital arthropathy-brachydactyly due to a novel monoallelic variant in TRPV4: A report of the fourth family
- Overexpression of LINC01605 promotes early tumorigenic phenotypes in primary human colon epithelial organoids
- Impact of MTHFR C677T polymorphism on recurrent spontaneous abortion: Bridging hyperhomocysteinemia, bile acid metabolism, and the epigenetic–immune axis
- Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy
- Identification of novel therapeutic targets for heart failure and its subtypes: Insights from proteomic and transcriptomic Mendelian randomization
- Characterization of cerebrospinal fluid and peripheral blood immune niche in a patient with primary neurolymphomatosis
- Exploring the transcriptional and post-transcriptional regulatory networks of methionine sulfoxide reductase B1 in breast cancer
- Critical roles of phosphorylation in multiple signaling pathways during the progression of osteoarthritis
- Novel post-translational modifications in fibrosis: The mechanisms and implications
- Circular RNAs as promising biomarkers for human diseases: An update for 2018–2025
- Effects of bile acids and gut microbiota interactions on neurological and psychiatric disorders
- Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and therapeutic implications
- Post-translational modifications of influenza virus proteins
- Molecular insights into fatty acid metabolism reprogramming: Targeting metabolic vulnerabilities in hematological malignancies
- The NEIL DNA glycosylase family: Molecular mechanisms, disease relevance, and therapeutic potential
- Role of N6-methyladenosine modification in pulmonary diseases
- Fusobacterium nucleatum-mediated tryptophan metabolic reprogramming facilitates immunosuppression and metastasis in triple-negative breast cancer
- Skin secretion of Andrias davidianus aqueous extract delays skin aging by suppressing the MAPK pathway
- 4P-model: A machine learning-driven approach to expand non-invasive prenatal testing for early risk stratification of placenta accreta spectrum via genome-wide cfDNA promoter profiling
- SOX4-activated lncRNA AC004854.2 promotes colorectal cancer progression by disrupting the PUF60–FUBP1 complex and activating c-MYC transcription
- The TGF-β/SMAD4 signaling pathway promotes the progression of papillary thyroid cancer by regulating IGF2BP2-mediated m6A modification of SPRY1 mRNA
- Cdc42ep1 regulated fibronectin expression in the TGF-β/cdc42 signaling pathway during epithelial–mesenchymal transition induced fibrosis
- A large-scale genome-wide and multi-omics investigation into the causality, shared genetic architecture, and gut microbiota feature linking diabetes to iridocyclitis